Purchasing peptides for research purposes generally remains legal in Canada, but clinical use without prescription falls into regulatory gray areas
In particular: NICE Technology Appraisal TA875 provides a positive recommendation for semaglutide (Wegovy) for chronic weight management in adults meeting specific criteria (BMI 35 kg/m with at least one weight-related comorbidity, or BMI 3034.9 kg/m in certain circumstances), when used within a specialist weight management service
For both therapeutic classes, this increased risk of gallbladder or biliary diseases has been thought to be driven by the inhibition of the secretion of cholecystokinin by GLP-1, leading to impaired gallbladder motility and contractility [64, 65]
Injection technique and timing Tirzepatide is administered as a once-weekly subcutaneous injection
For example, Ozempics FDA label was expanded in September 2023, shortly after the first lawsuits were filed, to include ileus as a possible gastrointestinal disorder
Fasting insulin drops 30% to 50% within 8 weeks in most patients (Frias et al., Diabetes Care , 2021)